These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10561921)

  • 1. Application of ChromaGen haploscopic lenses to patients with dyslexia: a double-masked, placebo-controlled trial.
    Harris D; MacRow-Hill SJ
    J Am Optom Assoc; 1999 Oct; 70(10):629-40. PubMed ID: 10561921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-masked placebo-controlled trial of precision spectral filters in children who use coloured overlays.
    Wilkins AJ; Evans BJ; Brown JA; Busby AE; Wingfield AE; Jeanes RJ; Bald J
    Ophthalmic Physiol Opt; 1994 Oct; 14(4):365-70. PubMed ID: 7845693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of blue-tinted lenses to change reading scores of dyslexic individuals.
    Christenson GN; Griffin JR; Taylor M
    Optometry; 2001 Oct; 72(10):627-33. PubMed ID: 11712629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Chromagen Lenses in Different Ocular and Non-ocular Conditions: A Prospective Cohort Study.
    Alkhudairy Z; Al Shamlan F
    Cureus; 2022 Sep; 14(9):e28963. PubMed ID: 36237810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new protocol for the optometric management of patients with reading difficulties.
    Lightstone A; Evans BJ
    Ophthalmic Physiol Opt; 1995 Sep; 15(5):507-12. PubMed ID: 8524584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scotopic sensitivity/Irlen syndrome and the use of coloured filters: a long-term placebo controlled and masked study of reading achievement and perception of ability.
    Robinson GL; Foreman PJ
    Percept Mot Skills; 1999 Aug; 89(1):83-113. PubMed ID: 10544403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ChromaGen contact lens system: colour vision test results and subjective responses.
    Swarbrick HA; Nguyen P; Nguyen T; Pham P
    Ophthalmic Physiol Opt; 2001 May; 21(3):182-96. PubMed ID: 11396392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the chromagen blue filter lens affect the reading speed, accuracy and contrast sensitivity.
    Bhandari M; Wei Ern RL; Majumder C; Ho D
    Med J Malaysia; 2019 Feb; 74(1):30-33. PubMed ID: 30846659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.
    Woo P; Southwood TR; Prieur AM; Doré CJ; Grainger J; David J; Ryder C; Hasson N; Hall A; Lemelle I
    Arthritis Rheum; 2000 Aug; 43(8):1849-57. PubMed ID: 10943876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects.
    Raj SM; Vasavada AR; Nanavaty MA
    J Cataract Refract Surg; 2005 Dec; 31(12):2324-8. PubMed ID: 16473225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of tinted contact lenses in the management of achromatopsia.
    Schornack MM; Brown WL; Siemsen DW
    Optometry; 2007 Jan; 78(1):17-22. PubMed ID: 17208670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.